PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-2.48%
Both companies show declining revenue. Martin Whitman would check for industry-wide issues.
-78.82%
Both companies reducing costs. Martin Whitman would check industry efficiency trends.
56.29%
Positive growth while VET shows decline. John Neff would investigate competitive advantages.
60.27%
Margin expansion while VET shows decline. John Neff would investigate competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both companies reducing G&A. Martin Whitman would check industry cost trends.
No Data
No Data available this quarter, please select a different quarter.
33.95%
Other expenses growth while VET reduces costs. John Neff would investigate differences.
26.19%
Operating expenses growth while VET reduces costs. John Neff would investigate differences.
-17.84%
Both companies reducing total costs. Martin Whitman would check industry trends.
-100.00%
Interest expense reduction while VET shows 14.29% growth. Joel Greenblatt would examine advantage.
2.02%
D&A growth less than half of VET's 4.41%. David Dodd would verify if efficiency is sustainable.
112.69%
EBITDA growth exceeding 1.5x VET's 47.21%. David Dodd would verify competitive advantages.
118.11%
EBITDA margin growth 1.25-1.5x VET's 82.38%. Bruce Berkowitz would examine sustainability.
674.16%
Operating income growth while VET declines. John Neff would investigate advantages.
688.77%
Operating margin growth while VET declines. John Neff would investigate advantages.
-7.69%
Other expenses reduction while VET shows 200.39% growth. Joel Greenblatt would examine advantage.
306.74%
Similar pre-tax income growth to VET's 355.49%. Walter Schloss would investigate industry trends.
312.00%
Pre-tax margin growth 50-75% of VET's 464.29%. Martin Whitman would scrutinize operations.
370.59%
Tax expense growth 1.1-1.25x VET's 307.44%. Bill Ackman would demand explanation.
293.08%
Net income growth while VET declines. John Neff would investigate advantages.
298.00%
Net margin growth while VET declines. John Neff would investigate advantages.
295.08%
EPS growth while VET declines. John Neff would investigate advantages.
293.44%
Diluted EPS growth while VET declines. John Neff would investigate advantages.
-0.54%
Share count reduction while VET shows 0.11% change. Joel Greenblatt would examine strategy.
-0.12%
Diluted share reduction while VET shows 0.11% change. Joel Greenblatt would examine strategy.